| dc.contributor.author | FALLON, PADRAIC | |
| dc.contributor.author | Fallon, Padraic | |
| dc.contributor.author | Alcami, Antonio | |
| dc.date | 2006 | en |
| dc.date.accessioned | 2025-01-12T20:37:55Z | |
| dc.date.available | 2025-01-12T20:37:55Z | |
| dc.date.issued | 2007-10-17 | |
| dc.date.submitted | 22-SEP-06 | en |
| dc.identifier | 40062 | en |
| dc.identifier | JOURNAL_ARTICLE | en |
| dc.identifier | 27 | en |
| dc.identifier | 10 | en |
| dc.identifier | Trends in Immunology | en |
| dc.identifier.citation | Fallon, P.G., Alcami. A., Pathogen-derived immunomodulatory molecules: future immunotherapeutics?, Trends in Immunology, 27, (10), 2006, p470 - 476 | en |
| dc.identifier.other | Y | |
| dc.description | PUBLISHED | en |
| dc.description.abstract | The identification of molecules from various pathogens
that modulate innate and/or adaptive immunity is a
dynamic and rapidly developing area of research. These
immunomodulatory molecules (IM) have been
optimized during pathogen–host co-evolution, and have
a potential application as novel immunotherapeutics. In
this review, we illustrate the use of pathogen IM that
have been produced as recombinant proteins, with different modes of modulatory activity, and discuss their
potential to modulate undesirable immune responses in
human diseases. | en |
| dc.format.extent | 470 | en |
| dc.format.extent | 476 | en |
| dc.language.iso | en | en |
| dc.rights | Y | en |
| dc.subject | Immunology | en |
| dc.title | Pathogen-derived immunomodulatory molecules: future immunotherapeutics? | en |
| dc.type | Journal Article | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.contributor.sponsor | Science Foundation Ireland | en |
| dc.identifier.uri | https://hdl.handle.net/2262/110632 | |
